VCRE
Vicore Pharma Holding AB
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$10.35
−0.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4953.75x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 32.47x
- Price / sales
- 2149.38x
- Price / cash flow
- -12.66x
Enterprise value
- Enterprise value
- $281.9M
- EV / sales
- 2079.15x
- EV / EBITDA
- -11.12x
- EV / EBIT
- -9.69x
- Market cap
- $291.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026